Alligator Bioscience AB (FRA:7AL0) FCF Margin %: 0.00% (As of Mar. 2026)

What is Alligator Bioscience AB FCF Margin %?

Alligator Bioscience AB FRA:7AL0 39 FCF Margin % is 0.00% as of Mar. 2026. GuruFocus rates FRA:7AL0 with a GF Score™ of 39/100. The stock has 7 warning signs investors should review. Among 959 Biotechnology companies, Alligator Bioscience AB ranks worse than 95.41% on this metric.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Alligator Bioscience AB's Free Cash Flow for the three months ended in Mar. 2026 was €-3.59 Mil. Alligator Bioscience AB's Revenue for the three months ended in Mar. 2026 was €0.00 Mil. Therefore, Alligator Bioscience AB's FCF Margin % for the quarter that ended in Mar. 2026 was 0.00%.

As of today, Alligator Bioscience AB's current FCF Yield % is -107.98%.

The historical rank and industry rank for Alligator Bioscience AB's FCF Margin % or its related term are showing as below:

FRA:7AL0' s FCF Margin % Range Over the Past 10 Years
Min: -30631.52 Med: -449.72 Max: -70.75
Current: -22100

During the past 12 years, the highest FCF Margin % of Alligator Bioscience AB was -70.75%. The lowest was -30631.52%. And the median was -449.72%.

FRA:7AL0's FCF Margin % is ranked worse than
95.41% of 959 companies
in the Biotechnology industry
Industry Median: -84.65 vs FRA:7AL0: -22100.00

Alligator Bioscience AB FCF Margin % Related Terms

Alligator Bioscience AB FCF Margin % Historical Data

* Premium members only.

The historical data trend for Alligator Bioscience AB's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Alligator Bioscience AB FCF Margin % Chart

Alligator Bioscience AB Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

FCF Margin %

Get a 7-Day Free Trial

-981.90

-484.79

-329.97

-383.93

-30,782.98

Alligator Bioscience AB Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
FCF Margin %	Get a 7-Day Free Trial															0.00	0.00	-7,202.33	-63,050.00	0.00

FRA:7AL0 vs VRTX, REGN, ALNY: FCF Margin % Comparison

For the Biotechnology subindustry, Alligator Bioscience AB's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Alligator Bioscience AB FCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Alligator Bioscience AB's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Alligator Bioscience AB's FCF Margin % falls into.

Save Embed

39GF Score

Alligator Bioscience AB FRA:7AL0

FCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Alligator Bioscience AB FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Alligator Bioscience AB's FCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2025 )	/	Revenue (A: Dec. 2025 )
	=	-14.468	/	0.047
	=	-30,782.98 %

Alligator Bioscience AB's FCF Margin for the quarter that ended in Mar. 2026 is calculated as

FCF Margin	=	Free Cash Flow (Q: Mar. 2026 )	/	Revenue (Q: Mar. 2026 )
	=	-3.588	/	0
	=	%

Frequently Asked Questions Learn more about FCF Margin % →

What does a FCF Margin % of 0.00% mean?

Alligator Bioscience AB (FRA:7AL0) has a FCF Margin % of 0.00% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Alligator Bioscience AB and its competitors. According to the industry distribution chart, Alligator Bioscience AB ranks #915 out of 959 companies in the Biotechnology industry, placing it in the top 95.4%.

Is Alligator Bioscience AB's FCF Margin % too high?

Alligator Bioscience AB's current FCF Margin % is 0.00%. Based on the distribution chart, Alligator Bioscience AB ranks #915 out of 959 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Alligator Bioscience AB has a GF Score™ of 39/100, reflecting its overall financial health beyond just this single metric.

How does Alligator Bioscience AB's FCF Margin % compare to VRTX and REGN?

According to the Biotechnology industry distribution chart, Alligator Bioscience AB ranks #915 out of 959 companies for FCF Margin %. This places Alligator Bioscience AB in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good FCF Margin % for a Biotechnology company?

A good FCF Margin % depends on the Biotechnology industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high FCF Margin % mean?

A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Alligator Bioscience AB and its competitors. Alligator Bioscience AB's current FCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Alligator Bioscience AB stock overvalued right now?

Alligator Bioscience AB (FRA:7AL0) has a current FCF Margin % of 0.00%. The current FCF Margin % is 0.00%. Alligator Bioscience AB's overall GF Score™ is 39/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is FCF Margin % calculated?

FCF Margin % is calculated from a company's financial statements. For Alligator Bioscience AB (FRA:7AL0), the current FCF Margin % is 0.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Alligator Bioscience AB Business Description

Industry Healthcare Biotechnology

Comparable Companies OSTO:SIMRIS B OSTO:NXTCL XSAT:ABERA OSTO:ELIC NGM:GTAB B OSTO:BIOVIC B OSTO:DMYD B OSTO:IRLAB A OSTO:ALZCUR OSTO:ANNX VRTX REGN XBRU:UCB XBRU:ARGX XKRX:207940 ALNY RVMD ASX:CSL ONC XKRX:068270

Other Exchanges ATORX:Sweden 0RK9:UK

Address Scheeletorget 1, Medicon Village, Lund, SWE, 223 81

Website https://www.alligatorbioscience.se

Alligator Bioscience AB is a clinical-stage biotechnology company developing tumor-directed immuno-oncology antibody drugs focused on the CD40 receptor. The company's main drug candidate, mitazalimab, is currently under development as a therapy for metastatic pancreatic cancer patients. Its development pipeline also comprises: ATOR-4066, a bispecific antibody targeting CD40, as well as CEACAM5 (carcinoembryonic antigen 5), a protein found in certain tumors; and certain externally developed programs like HLX22 and ALG.APV-527. Geographically, the company generates maximum revenue from Belgium (mainly through out-licensing), and also has its presence in Sweden and Finland.

39GF Score

Get the complete analysis for FRA:7AL0

FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.00

Price

View FRA:7AL0 Analysis

See FCF Margin % data for all stocks →